Back
Sarepta Therapeutics 10K Form
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
126.28
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SRPT News And Ratings
See the #1 stock for the next 7 days that we like better than SRPT
SRPT Financial Statistics
Sales & Book Value
Annual Sales: | $933.01M |
---|---|
Cash Flow: | $-218.88M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.65 |
Price / Book: | 16.36 |
Profitability
EPS (TTM): | -12.69000 |
---|---|
Net Income (TTM): | $-1.12B |
Gross Margin: | $793.02M |
Return on Equity: | -179.19% |
Return on Assets: | -36.22% |
Sarepta Therapeutics Earnings Forecast
Key Sarepta Therapeutics Financial Ratios
- The Gross Profit Margin over the past 27 years for SRPT is 85.00%.
- The Selling, General & Administrative Expenses for SRPT have been equal to 48.38% of Gross Profit Margin.
- The Research & Development expenses have been 94.01% of Revenue.
- The Interest Expense is -7.57% of Operating Income.
- The Net Earning history of SRPT is -75.40% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 13 years.
Sarepta Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | SRPT |
CUSIP: | 803607 |
Website: | sarepta.com |
Debt
Debt-to-Equity Ratio: | 1.73 |
---|---|
Current Ratio: | 4.63 |
Quick Ratio: | 4.04 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 17.7 |
SRPT Technical Analysis vs Fundamental Analysis
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $125.16. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.